Company Data

Arch Biopartners Inc

Ticker
ACHFF
Current Price
$1.3501 0.23%
Market Cap
$87.3M
Price Target
Refer to Report
Volume
1.1K
52wk Range
$0.8925 - $1.88
Advanced Market Data

Overview

Arch Biopartners Inc is a clinical-stage company. Its pipeline consists of: MetaBlok that is a new drug candidate and potential treatment for inflammation, sepsis and cancer metastasis. AB569 is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs. BORG is a group of novel synthetic peptides and peptide conjugates that employ novel chemistry to react with solid surfaces such as metals, and plastics to generate new materials that display new surface properties. MetaMx is composed of a novel, synthetic peptides that target and attach to BTICs and invasive glioma cells, for the purpose of imaging, diagnosis and developing targeted therapies to improve patient outcomes and survival rates among glioblastoma patients.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy